The KidneyCARE (Community Access to Research Equity) Study
Part of paid clinical trials in Danville, Pennsylvania.
- Sponsor
- Tufts Medical Center
- Study ID
- NCT05497518
- Status
- Recruiting
Conditions
- Chronic Kidney Disease
- Dialysis
- Kidney Transplant
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 120 Years
- Healthy Volunteers
- Not accepted
Interventions
- Observational study - registry — OTHERThe Study is a longitudinal observational cohort study that collaborates with health systems to obtain both electronic healthcare records (EHR) and patient-entered data. Eligible people with a diagnosis of chronic kidney disease at any stage, age 18 years and above, are identified through EHR data review, referral by a provider, or are recruited through the NKF's outreach campaign. Patients self-enroll into the online registry and share their experiences and health data through a secure portal where they can also find education, tips, and support. Research partners can view aggregate data through a collaboration portal.
Study Details
For chronic kidney disease (CKD), there is a lack of unique and powerful platform for patient engagement, research studies and public health advocacy work. The National kidney Foundation (NKF) launched the first nationwide registry for people at all stages and types of CKD, including people on dialysis and kidney transplant recipients, called the KidneyCARE Study (kidneycarestudy.org). The KidneyCARE Study is a non-interventional research study which means participants will not have to take medications or do any additional tests to participate. They are simply asked to share some personal and health information, and their experiences with their disease through a secure portal. The Study also collaborates with health systems to obtain additional electronic health records (EHR) data. This unique combination of data collected will address the gap of individualized educational resources and will enhance clinical research, clinical care, and health policy decisions to be centered on the patient. The Study is all online and can be accessed any time of day at kidneycarestudy.org. Participation is voluntary and free.
Key Dates
- Start date
- Feb 25, 2021
- Status verified
- May 2025
- Primary completion
- Feb 24, 2070
- Completion
- Feb 24, 2070
Study Design
- Enrollment
- 50,000 participants (estimated)
Arms
- Arm: People with chronic kidney diseaseNo interventions will be administered as part of this registry.
Primary Outcome Measure
Total number of enrolled participants [ Time Frame: 5 years ]
Central Contacts
- Lesley A Inker, MD, MS617-636-2569
- Kerry Willis, PhD212-889-2210
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Geisinger Clinic | Danville | Pennsylvania | 17822 | Alexander Chang, MD, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Danville, PA
Related Studies
- Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)Recruiting · Johns Hopkins Bloomberg School of Public Health · Kansas City, Missouri
- Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal CenterRecruiting · University of Michigan · Ann Arbor, Michigan
- A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on HemodialysisPHASE3 · Recruiting · Amgen · Los Angeles, California
- A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and ProteinuriaPHASE3 · Recruiting · Bayer · Phoenix, Arizona